Search
Cardiology
Endocrinology
Dermatology
Geriatrics
Psychiatry
Pulmonology
Search
Newer Treatment Options to Manage Sickle Cell Disease - Episode 5
Managing Novel Therapy AEs in Sickle Cell Disease
December 22, 2020
HCP Live
HCP Live
EP. 1: Efficacy and Safety from the 72-Week Analysis of the HOPE Study
EP. 2: Clinical Implications and Evidence for the Treatment of Sickle Cell
EP. 3: Treatment Goals and Role of New Therapies for SCD
EP. 4: Voxelotor and Crizanlizumab: Safety and Tolerability
Now Viewing
EP. 5: Managing Novel Therapy AEs in Sickle Cell Disease
Related Content:
Newer Treatment Options to Manage Sickle Cell Disease
Sickle Cell
Hemodialysis Patients Likely to Experience Anxiety, Depression
Unmet Needs in Sickle Cell Disease Management
Kim Smith-Whitley, MD: Sickle Cell, COVID-19, and Building Trust in the Vaccines
x
